Aclarion, Inc. announced that its Nociscan magnetic resonance spectroscopy (MRS) technology was used in a new award-winning study to identify immune-related biological signatures in some chronic low back pain patients with Modic type 1 changes. The study found elevated propionic acid levels inside lumbar discs, linked to immune activation involving B-cells, suggesting some back pain may have an immune or bacterial component beyond mechanical causes. This expands Nociscan's clinical use from surgical decision support to potentially guiding personalized treatments like anti-inflammatory or immune-modulating therapies, offering more precise spine care in the future.
Xos announced a $3 million follow-on order for 12 mobile energy storage and charging systems from a leading autonomous fleet operator, supporting expansion in North America and Europe. This order highlights rising demand for mobile charging solutions...
Meta Platforms is collaborating with Reliance Industries to build its first AI-enabled data center in India, a 168-megawatt facility in Jamnagar, Gujarat. This project, expected to be completed within two years, will support Meta's global AI computin...
SpaceX's upcoming IPO is valued at $1.77 trillion, exceeding the combined $1.5 trillion valuation of all 12 aerospace companies in the S&P 500. Despite lower revenue than these firms, SpaceX's valuation reflects strong investor optimism, with some pr...
Lantronix and Cherry & White have jointly developed a rapid Wi-Fi platform that delivers enterprise-grade 5G connectivity to critical infrastructure like utilities, emergency services, and remote industrial sites. The platform uses Lantronix's rugged...
US stock futures declined following mixed market closes and geopolitical tensions after President Trump ordered strikes against Iran. Investors await May's CPI data expected to show a 4.2% annual increase, the highest since April 2023, influencing Fe...
